Funding for this research was provided by:
First Online: 27 April 2020
Compliance with ethical standards
: Alessandro Faragli is a shareholder of the Company BOCAhealthcare GmbH. Burkert Pieske reports having received consultancy and lecture honoraria from Bayer, Daiichi Sankyo, MSD, Novartis, Sanofi-Aventis, Stealth Peptides, and Vifor Pharma; and editor honoraria from the Journal of the American College of Cardiology. Burkert Pieske, Frank Edelmann, and Sebastian Kelle received funding from the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). Sebastian Kelle received an unrestricted research grant from Philips Healthcare and received lecture honoraria from Medis, NL. Dawud Abawi, Caroline Quinn, Mina Cvetokovic, Thomas Schlabs, Elvis Tahirovic, and Hans-Dirk Düngen have no conflicts of interest or financial ties to disclose.